Trends in lipid management among patients with coronary artery disease: Has diabetes received the attention it deserves?

Diabetes Care

Volumn 26, Issue 4, 2003, Pages 991-997

  Massing, Mark W ^a,b   Foley, Kathleen A ^c   Sueta, Carla A ^a,d   Chowdhury, Mridul ^a   Biggs, David P ^a   Alexander, Charles M ^c   Simpson Jr , Ross J ^a,d  

^a Medical Review of North Carolina   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; OUTPATIENT; PATIENT CARE; QUALITY CONTROL;

AGED; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; GEOGRAPHY; HUMANS; LIPIDS; MALE; RETROSPECTIVE STUDIES; SELF CARE;

EID: 0042594647     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.4.991     Document Type: Article

References (31)

1. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 2:120-126, 1979
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
3. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A: Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102: 1014-1019, 2000
4. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J: Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21:69-75, 1998
5. Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel LM, Christlieb AR: Evolving natural history of coronary disease in diabetes mellitus. Am J Med 90: 56S-61S, 1991
6. Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP: Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival: the Minnesota Heart Study. Diabetes Care 14:537-543, 1991
7. Fagan TC, Sowers J: Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy. Arch Intern Med 159:1033-1034, 1999
8. Wingard DL, Barrett-Connor E: Heart disease and diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Washington, DC, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995, p. 429-448 (NIH publication 95-1468)
9. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabete Metab Rev 3:463-524, 1987
10. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
11. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G, the Scandinavian Simvastatin Survival Study (4S) Group: Cholesterol lowering wth Simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
12. Sacks F, Pfeffer M, Moye L, Rouleau J, Rutherford J, Cole T, Brown L, Warnica W, Arnold J, Wun C, Davis B, Braunwald E for the Cholesterol and Recurrent Events Trial Investigators: The effect of Pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001-1009, 1996
13. The Long-term Intervention with Pravastatin in Ischaemic Disease (Lipid) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 39:1349-1357, 1998
14. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22, 2002
15. Sueta CA, Chowdhury M, Boccuzzi SJ, Smith SC Jr, Alexander CM, Londhe A, Lulla A, Simpson RJ: Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol 83: 1303-1307, 1999
16. Massing MW, Sueta CA, Chowdhury M, Biggs DP, Simpson RJ Jr: Lipid management among coronary artery disease patients with diabetes mellitus or advanced age. Am J Cardiol 87:646-649, 2001
17. Pearson T, Peters T: The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol 80:45H-52H, 1997
18. Fonarow G, Gawlinksi A, Moughrabi S, Tillisch J: Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 87:819-822, 2001
19. Pearson T, Laurora I, Chu H, Kafonek S: The Lipid Treatment Assessment Project. Arch Intern Med 160:459-467, 2000
20. American Diabetes Association: Management of dyslipidemia in adults with diabetes. Diabetes Care 25 (Suppl. 1)574-577, 2002
21. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): JAMA 285:2486-2497, 2001
22. St. Anthony's ICD-9-CM Code Book. Schmidt KM, Hart AC, Aaron WS, Eds. Reston, VA, St. Anthony's Publishing 1998
23. Calder R, Alexander CM: Cardiovascular disease in diabetes. Practical Diabetology 19:7-18, 2000
24. Menotti A, Kromhout D, Nissinen A, Giampaoli S, Seccareccia F, Feskens E, Pekkanen J, Tervahauta M: Short-term all-cause mortality and its determinants in elderly male populations in Finland, The Netherlands and Italy: the FINE Study. Finland, Italy, Netherland Elderly Study. Prev Med 25:319-326, 1996
25. Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PW: Effects of age, gender and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35:779-792, 1994
26. McGill HC, McMahan CA, Herderick EE, Tracy RE, Malcom GT, Zieske AW, Strong JP: Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. Atherioscler Thromb Vasc Biol 20:836-845, 2000
27. McGill HC, McMahan CA, Zieske AW, Tracy RE, Malcom GT, Herderick EE, Strong J: Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 102:374-379, 2000
28. National Diabetes Education Program: Control the ABCs of Diabetes [article online], 2002. Available from http://www. ndep.nth.gov/control/control.htm. Accessed 16 October 2002
29. American Diabetes Association: Make the Link: Diabetes, Heart Disease, and Stroke [article online], 2002. Available from http://www.diabetes.org/main/info/link.jsp. Accessed 16 October 2002
30. Huse D, Roht L, Alpert J, Hartz S: Physician knowledge, attitudes and practice of pharmacologic treatment of hypertension. Ann Pharmacother 35:1173-1179, 2001
31. Larme A, Pugh J: Attitudes of primary care physicians toward diabetes: barriers to guideline implementation. Diabetes Care 21:1391-1396, 1998